Development of pharmacist-managed preventive medication assesment program in a family physician office setting: The medication checkup

Canadian Journal of Hospital Pharmacy

Volumn 55, Issue 5, 2002, Pages 320-328

  Kennie, Natalie ^a   Bajcar, Jana ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Ambulatory care; Family practice; Health promotion; Pharmaceutical care; Program evaluation; Program implementation

Indexed keywords

ARTICLE; GENERAL PRACTICE; HEALTH PROGRAM; HUMAN; MEDICAL LITERATURE; OUTPATIENT DEPARTMENT; PATIENT ATTITUDE; PATIENT CARE; PATIENT COMPLIANCE; PATIENT REFERRAL; PHARMACIST; PILOT STUDY; QUESTIONNAIRE; RETROSPECTIVE STUDY;

EID: 0036868925     PISSN: 00084123     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. American College of Clinical Pharmacy. Establishing and evaluating clinical pharmacy services in primary care. Pharmacotherapy 1994;14:743-58.
2. Chrischilles EA, Helling DK, Aschoff CR. Effect of clinical pharmacy services on the quality of family practice physician prescribing and medication costs. DCIP Ann Pharmacother 1989;23:417-21.
3. Haxby DG, Weart CW, Goodman BW Jr. Family practice physicians' perceptions of the usefulness of drug therapy recommendations from clinical pharmacists. Am J Hosp Pharm 1988;45:824-7.
4. Britton ML, Lurvey PL. Impact of medication profile review on prescribing in a general medicine clinic. Am J Hosp Pharm 1991;48:265-70.
5. Lobas NH, Lepinski PW, Abramowitz PW. Effects of pharmaceutical care on medication cost and quality of patient care in an ambulatory-care clinic. Am J Hosp Pharm 1992;49:1681-8.
6. Wong C, Cave A, Jarman R. Pharmaceutical care in a family medicine centre. Can Pharm J 1997;130:35-6,38-40,42-3.
7. Campbell RK, Saulie BA. Providing pharmaceutical care in a physician's office. J Am Pharm Assoc (Wash) 1998;NS38:485-9.
8. Johnson JA, Bootman JL. Drug-related morbidity and mortality and the economic impact of pharmaceutical care. Am J Health Syst Pharm 1997;54:554-8.
9. Bajcar J, Vaillancourt R. Integrated delivery of pharmaceutical care in family practice: a case example. Pharm Connect 1996;Sept/Oct:26-33.
10. Hepler CD, Strand, LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47:533-43.
11. Billups SJ, Okano G, Malone D, Carter BL, Valuck R, Barnette DJ, et al. Assessing the structure and process for providing pharmaceutical care in Veterans Affairs medical centers. Am J Health Syst Pharm 2000;57:29-39.
12. Hautoum HT, Akhras K. 1993 bibliography: a 32-year literature review on the value and acceptance of ambulatory care provided by pharmacists. Ann Pharmacother 1993;27:1106-19.
13. Segarra-Newnham M, Soisson KT. Provision of pharmaceutical care through comprehensive pharmacotherapy clinics. Hosp Pharm 1997;32:845-50.
14. Chandler C, Barriuso P, Rozenberg-Ben-Dror K, Schmitt B. Pharmacists on a primary care team at a Veterans Affairs medical center. Am J Health Syst Pharm 1997;54:1280-7.
15. Alsuwaidan S, Malone DC, Billups SJ, Carter BL. Characteristics of ambulatory care clinics and pharmacists in Veterans Affairs medical centers. Am J Health Syst Pharm 1998;55:68-72.
16. Shimp LA, Glazer HM, Reinke CM, Ascione FJ, Peggs JF, Reinhardt RW. A systematic approach to identifying and reducing medication-related problems in family practice patients. Fam Pract Res J 1986;5:247-54.
17. Koecheler JA, Abramowitz PW, Swim SE, Daniels CE. Indicators for the selection of ambulatory patients who warrant pharmacist monitoring. Am J Hosp Pharm 1989;46:729-32.
18. Leinweber CE, Campbell HS, Trottier DL. Is health promotion campaign successful in retail pharmacies? Can J Public Health 1995;86:380-3.
19. Paluck EC, Stratton TP, Eni GO. Community pharmacists' participation in health education and disease prevention activities. Can J Public Health 1994;85:389-92.
20. Gilbert L. The role of the community pharmacist as an oral health advisor - an exploratory study of community pharmacists in Johannesburg, South Africa. SADJ 1998;53:439-43.
21. Mayer JA, Slymen DJ, Eckhardt L, Rosenberg C, Stepanski BM, Creech L, et al. Skin cancer prevention counseling by pharmacists: specific outcomes of an intervention trial. Cancer Detect Prev 1998;22:367-75.
22. Mayer JA, Eckhardt L, Stepanski BM, Sallis JF, Elder JP, Slymen DJ, et al. Promoting skin cancer prevention counseling by pharmacists. Am J Public Health 1998;88:1096-9.
23. Jungnickel PW, Wisehart DA. Evaluation of community pharmacists' experiences with cholesterol screening programs. J Am Pharm Assoc (Wash) 1997;NS37:640-6.
24. Gardner JS. A practical guide to establishing vaccine administration services in community pharmacies. J Am Pharm Assoc (Wash) 1997;NS37:683-92.
25. Strand LM, Morley PC, Cipolle RJ, Ramsey R, Lamsam GD. Drug-related problems: their structure and function. DICP Ann Pharmacother 1990;24:1093-7.
26. Herrier RN. Medication compliance in the elderly. J Pharm Pract 1995;8:232-44.
27. Lamy PP. The elderly, communications and compliance. Pharm Times 1992;58(Aug):33-4,37-8,41-2,44,47.
28. Kruse WHH. Comprehensive geriatric assessment and medication compliance. Z Gerontol Geriatr 1995;28:54-61.
29. Brown TER. Compliance case scenarios. Pharm Pract 1996;12(2):70-6.
30. Fitten LJ, Coleman L, Siembieda DW, Yu M, Ganzell S. Assessment of capacity to comply with medication regimens in older patients. J Am Geriatr Soc 1995;43:361-7.
31. Ruscin MJ, Semla TP. Assessment of medication management skills in older outpatients. Ann Pharmacother 1996;30:1083-8.
32. Corlett AJ. Aids to compliance with medication. BMJ 1996;313:926-9.
33. Ennis KJ, Reichrad RA. Maximizing drug compliance in the elderly. Tips for staying on top of your patients' medication use. Postgrad Med 1997; 102(3):211-3,218,223-4.
34. Coambs RB, Junsen P, Hao Her M, Ferguson BS, Jarry JL, Wong JS, et al. Review of the scientific literature on the prevalence, consequences, and health costs of noncompliance and inappropriate use of prescription medication in Canada. Toronto (ON): Pharmaceutical Manufacturers Association of Canada; 1995.
35. Donabedian A. The quality of care. How can it be assessed? JAMA 1988;260:1743-8.
36. Patient outcomes of pharmaceutical interventions: a scientific foundation for the future [invitational conference]. Washington (DC): American Pharmaceutical Association; 1994 Nov.